Name: Zhang Zhen

Education & Professional Experience   Feb.2004 - Oct.2007: Oncology, Fudan University Degree: Ph.D 
Sept.2000-Oct.2001: Clinical Observer, Dept.of Radiation Oncology, M.D.Anderson Cancer Center, The University of Texas.
Sept.1999 - June 2003: Oncology, Fudan University Degree: Master 
May 1995-June 1995: Visiting Scholar, Department of Radiation Oncology, Queen Mary Hospital, Hong Kong 
Sept.1982 - July 1988: Medical School, Shanghai Medical University Degree: MD
Specialty   GI cancer
Research   1.Phase II study of pre-operative concurrent chemoradiation in the treatment of locally advanced rectal cancer. (Wu Jieping Foundation, Ministry of Health, Primary Investigator)
2.Evaluation of COX-2 expression to predict the response of pre-operative concurrent chemoradiation in the treatment of locally advanced rectal cancer. (Science and Technology Commission of Shanghai Municipality, Primary Investigator)
3.Biomarker of prediction the response of concurrent chemoradiation in the treatment of locally advanced rectal cancer. (Cancer Hospital, Primary Investigator)
Publication   Zhang Z, Liu HH, Liao ZX, et al. Analysis of dose-volume dependence of acute esophagitis using a random-effect model for concurrent chemoradiation therapy for non-small-cell lung cancer (NSCLC). China Oncology Vol.14No.6:527-531,2004
Zhang Z, Liao Z, Jin J, et al. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005;61(3):656-64
Zhang Z, Xie SX. Comparison of result in post-operative treatment of gastric or gastricesophageal cancinoma with or without chemoradiation. J Evidence-based Med. 2005, 5(4)218-221
Ren J, Zhang Z, Wu XY, et al. Feasibility study to apply EPID by trained therapists in evaluation of set-up errors of pelvic irradiation. China Oncology Vol.16(12):1043-1045, 2006 (Corresponding Author)
Zhang Z, Liu HH, Liao ZX, et al. Applying random-effect model and maximum-likelihood analysis in the dose and time dependence of acute esophagitis for concurrent chemoradiation therapy for non-small-cell lung cancer (NSCLC). China Oncology Vol.16(12):1028-1033, 2006
Wu XY, Zhang Z, Wang WC, et al. Evaluation of set-up errors in pelvic irradiation with electronic portal imaging device. Chin J Radiat Oncol. 16(1):52-54,2007-5-21 (Corresponding Author)
Ma XJ, Zhang Z, Lu JD, et al. Significance of CT scan in the early follow-up after definitive radiotherapy of nasopharyngeal cancer. China Oncology Vol.17 No.2, 2007 (Corresponding Author)
Hu WG, Zhang Z, Xu ZY, et al. Dose distribution comparison between 3D conformal and IMRT plan in post-operative gastric cancer treatment. Chin J Radiat Oncol (accepted) (Corresponding Author)
Zhang Z. Advances in clinical investigation of adjuvant radiotherapy in rectal cancer. China Oncology , 2006,(06):417-420
Zhang Z, Chen Y, Chen YZ, et al. Outcomes with esophageal cancer radiation therapy. J Thorac Oncol 2009; 4 (7):1-9
Weigang Hu, Jinsong Ye, Zhen Z, et al. Use of Kilovoltage X-ray volume imaging in patient dose calculation for head-and-neck and partial brain radiation therapy. Radiation Oncology 2010: 5:29 (Corresponding Author)
Wenjie Sun, Cheng N Leong, Zhen Z, et al. Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer:apooled analysis of clinical evidence. Radiation Oncology 2010: 5:28 (Corresponding Author)
Liao Z, Zhang Z, Jin J, et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 2004;60(5):1484-93.
Jin J, Liao Z, Zhang Z, Ajani J, et al. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004;60(2):427-36.
Pan ZQ, Zhang Z, He XY, et al. Analysis of phase III randomized trial of conventional irradiation versus hyperfractionated irradiation with late course concommitant boost in nasopharyngeal carcinoma. China Oncology. 2005, (1):44-47
Ma XJ, Guo XM, Zhang Z, et al. Postoperative radiotherapy for stage II/III rectal cancer. China Oncology, 2006, 16(3):51-54
Wu KL, Jiang GL, …Zhang Z, et al. Phase I clinical trial of dose escalation on three dimensional conformal radiation therapy for non-small cell lung cancer. Chinese J Lung Cancer. 2000,(5):322-325
Wu KL, Jiang GL, …Zhang Z, et al. Reirradiation fo recurrent after lung cancer radiotherapy using 3 dimensional conformal radiotherapy. China Oncology, 2000,(5):27-29
Zhao WX, Zhang Z. Adjuvant radiotherapy in operated gastric cancer. China Oncology. 2002 (6) (review)

Awards   N/A
Out-patient Schedule  

Wednesday morning